Hepatitis B virus burden in developing countries

World Journal of Gastroenterology

Volumn 21, Issue 42, 2015, Pages 11941-11953

  Zampino, Rosa ^a   Boemio, Adriana ^a   Sagnelli, Caterina ^a   Alessio, Loredana ^a   Adinolfi, Luigi Elio ^a   Sagnelli, Evangelista ^a   Coppola, Nicola ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Chronic hepatitis; Developing countries; Hepatitis B virus; Molecular epidemiology; Prevention

Indexed keywords

AFRICA; AMERICAN; ARTICLE; CHRONIC HEPATITIS; DEVELOPING COUNTRY; EASTERN EUROPE; EASTERN EUROPEAN; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; MEDICAL INFORMATION; MOLECULAR BIOLOGY; MOLECULAR EPIDEMIOLOGY; PREVALENCE; SOUTH AND CENTRAL AMERICA; VACCINATION; VIRUS LOAD; ACUTE DISEASE; ASIA; EUROPE; HEPATITIS B, CHRONIC; INCIDENCE; PROGNOSIS; RISK FACTOR; TIME FACTOR; TRANSMISSION;

ACUTE DISEASE; AFRICA; ASIA; DEVELOPING COUNTRIES; EUROPE; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LATIN AMERICA; MOLECULAR EPIDEMIOLOGY; PREVALENCE; PROGNOSIS; RISK FACTORS; TIME FACTORS;

EID: 84947434020     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i42.11941     Document Type: Article

References (186)

1. WHO. Hepatitis B. Available from: URL: http://www.who.int/mediacentre/factsheets/fs204/en/
2. Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 2007; 37: S9-S19 [PMID: 17627641 DOI: 10.1111/j.1872-034X.2007.00098.x]
3. WHO. Relevè Epidemiologique hebdomadair. 2002. Available from: URL: http://www.who.int/wer/fr/
4. Tao I, Compaoré TR, Diarra B, Djigma F, Zohoncon TM, Assih M, Ouermi D, Pietra V, Karou SD, Simpore J. Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso. Hepat Res Treat 2014; 2014: 781843 [PMID: 25161770 DOI: 10.1155/2014/781843]
5. Pietra V, Kiema D, Sorgho D. Prevalence of Hepatitis B virus markers and hepatitis C virus antibodies in health staff in the District of Nanoro, Burkina Faso. Science and Technology, Science Sant'e 2008; 31: 1-2
6. Collenberg E, Ouedraogo T, Ganamé J, Fickenscher H, Kynast-Wolf G, Becher H, Kouyaté B, Kräusslich HG, Sangaré L, Tebit DM. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol 2006; 78: 683-692 [PMID: 16555290 DOI: 10.1002/jmv.20593]
7. Simpore J, Granato M, Santarelli R, Nsme RA, Coluzzi M, Pietra V, Pignatelli S, Bere A, Faggioni A, Angeloni A. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol 2004; 31: 78-80 [PMID: 15288619 DOI: 10.1016/j.jcv.2004.06.001]
8. Belo AC. Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria. East Afr Med J 2000; 77: 283-285 [PMID: 12858922]
9. Bada AS, Olatunji PO, Adewuyi JO, Iseniyi JO, Onile BA. Hepatitis B surface antigenaemia in Ilorin, Kwara State, Nigeria. Cent Afr J Med 1996; 42: 139-141 [PMID: 8771932]
10. Sadoh AE, Sadoh WE. Serological markers of hepatitis B infection in infants presenting for their first immunization. Niger J Paeadiatr 2013; 40: 248-253 [DOI: 10.4314/njp.v40i3.9]
11. Fouelifack Ymele F, Keugoung B, Fouedjio JH, Kouam N, Mendibi S, Dongtsa Mabou J. High Rates of Hepatitis B and C and HIV Infections among Blood Donors in Cameroon: A Proposed Blood Screening Algorithm for Blood Donors in Resource-Limited Settings. J Blood Transfus 2012; 2012: 458372 [PMID: 24066258 DOI: 10.1155/2012/458372]
12. Noubiap JJ, Joko WY, Nansseu JR, Tene UG, Siaka C. Seroepidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Int J Infect Dis 2013; 17: e832-e837 [PMID: 23317526 DOI: 10.1016/j.ijid.2012.12.007]
13. Euler GL, Wooten KG, Baughman AL, Williams WW. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics 2003; 111: 1192-1197 [PMID: 12728137]
14. Njouom R, Pasquier C, Ayouba A, Tejiokem MC, Vessiere A, Mfoupouendoun J, Tene G, Eteki N, Lobe MM, Izopet J, Nerrienet E. Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg 2005; 73: 460-466 [PMID: 16103623]
15. Fomulu NJ, Morfaw FL, Torimiro JN, Nana P, Koh MV, William T. Prevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon? BMC Pregnancy Childbirth 2013; 13: 158 [PMID: 23924215 DOI: 10.1186/1471-2393-13-158]
16. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30: 2212-2219 [PMID: 22273662 DOI: 10.1016/j.vaccine.2011.12.116]
17. Komas NP, Vickos U, Hübschen JM, Béré A, Manirakiza A, Muller CP, Le Faou A. Cross-sectional study of hepatitis B virus infection in rural communities, Central African Republic. BMC Infect Dis 2013; 13: 286 [PMID: 23800310 DOI: 10.1186/1471-23 34-13-286]
18. Peto TJ, Mendy ME, Lowe Y, Webb EL, Whittle HC, Hall AJ. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program. BMC Infect Dis 2014; 14: 7 [PMID: 24397793 DOI: 10.1186/1471-2334-14-7]
19. Bovet P, Yersin C, Herminie P, Lavanchy D, Frei PC. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bull World Health Organ 1999; 77: 923-928 [PMID: 10612888]
20. Chiaramonte M, Stroffolini T, Ngatchu T, Rapicetta M, Lantum D, Kaptue L, Chionne P, Conti S, Sarrecchia B, Naccarato R. Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol 1991; 33: 95-99 [PMID: 2051143]
21. Sirisena ND, Njoku MO, Idoko JA, Isamade E, Barau C, Jelpe D, Zamani A, Otowo S. Carriage rate of hepatitis-B surface antigen (HBsAg) in an urban community in Jos, Plateau State, Nigeria. Niger Postgrad Med J 2002; 9: 7-10 [PMID: 11932753]
22. Jacobs B, Mayaud P, Changalucha J, Todd J, Ka-Gina G, Grosskurth H, Berege ZA. Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm Dis 1997; 24: 121-126 [PMID: 9132977]
23. Bile K, Mohamud O, Aden C, Isse A, Norder H, Nilsson L, Magnius L. The risk for hepatitis A, B, and C at two institutions for children in Somalia with different socioeconomic conditions. Am J Trop Med Hyg 1992; 47: 357-364 [PMID: 1524149]
24. Tswana SA, Moyo SR. The interrelationship between HBVmarkers and HIV antibodies in patients with hepatocellular carcinoma. J Med Virol 1992; 37: 161-164 [PMID: 1279108]
25. Abiodun PO, Olomu A, Okolo SN, Obasohan A, Freeman O. The prevalence of hepatitis Be antigen and anti-HBE in adults in Benin City. West Afr J Med 1994; 13: 171-174 [PMID: 7841109]
26. Hodges M, Sanders E, Aitken C. Seroprevalence of hepatitis markers; HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med 1998; 17: 36-37 [PMID: 9643158]
27. Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T, Cutts FT. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect 2003; 131: 757-770 [PMID: 12948377]
28. Odaibo GN, Arotiba JT, Fasola AO, Obiechina AE, Olaleye OD, Ajagbe HA. Prevalence of hepatitis B virus surface antigen (HBsAg) in patients undergoing extraction at the University College Hospital, Ibadan. Afr J Med Med Sci 2003; 32: 243-245 [PMID: 15030081]
29. Jombo GT, Egah DZ, Banwat EB. Hepatitis B virus infection in a rural settlement of northern Nigeria. Niger J Med 2005; 14: 425-428 [PMID: 16353707]
30. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 2005; 100: 13-16 [PMID: 15867956]
31. Kirk GD, Bah E, Montesano R. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 2006; 27: 2070-2082 [PMID: 16679307 DOI: 10.1093/carcin/bgl060]
32. Heikel J, Sekkat S, Bouqdir F, Rich H, Takourt B, Radouani F, Hda N, Ibrahimy S, Benslimane A. The prevalence of sexually transmitted pathogens in patients presenting to a Casablanca STD clinic. Eur J Epidemiol 1999; 15: 711-715 [PMID: 10555614]
33. Iorio R, Giannattasio A, Cirillo F, D' Alessandro L, Vegnente A. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clin Infect Dis 2007; 45: 943-949 [PMID: 17879906 DOI: 10.1086/521864]
34. Hadziyannis SJ. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1995; 1: 7-36
35. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2001; 34: 617-624 [PMID: 11584355 DOI: 10.1053/jhep.2001.27834]
36. Acquaye JK, Mingle JA. Hepatitis B viral markers in Ghanaian pregnant women. West Afr J Med 1994; 13: 134-137 [PMID: 7841099]
37. Harry TO, Bajani MD, Moses AE. Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East Afr Med J 1994; 71: 596-597 [PMID: 7875094]
38. Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med 1999; 45: 195-198 [PMID: 10697914]
39. Guidozzi F, Schoub BD, Johnson S, Song E. Should pregnant urban south African women be screened for hepatitis B? S Afr Med J 1993; 83: 103-105 [PMID: 8451683]
40. Roingeard P, Diouf A, Sankale JL, Boye C, Mboup S, Diadhiou F, Essex M. Perinatal transmission of hepatitis B virus in Senegal, west Africa. Viral Immunol 1993; 6: 65-73 [PMID: 8476509]
41. Oshitani H, Kasolo F, Tembo C, Mpabalwani M, Mizuta K, Luo N, Suzuki H, Numazaki Y. Hepatitis B virus infection among pregnant women in Zambia. East Afr Med J 1995; 72: 813-815 [PMID: 8689985]
42. Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, Acosta C, Lopez-Labrador X, Olmedo E, Navia M, Tanner M, Rodes J, Alonso PL. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999; 58: 215-220 [PMID: 10447415]
43. Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut 1996; 38 Suppl 2: S5-S12 [PMID: 8786055]
44. Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and metaanalysis. Int J Infect Dis 2010; 14: e1024-e1031 [PMID: 20870439 DOI: 10.1016/j.ijid.2010.06.013]
45. Day SL, Odem-Davis K, Mandaliya KN, Jerome KR, Cook L, Masese LN, Scott J, Kim HN, Graham SM, McClelland RS. Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy. PLoS One 2013; 8: e59346 [PMID: 23527168 DOI: 10.1371/journal.pone.0059346]
46. Ayuk J, Mphahlele J, Bessong P. Hepatitis B virus in HIV-infected patients in northeastern South Africa: prevalence, exposure, protection and response to HAART. S Afr Med J 2013; 103: 330-333 [PMID: 23971125]
47. Ladep NG, Agaba PA, Agbaji O, Muazu A, Ugoagwu P, Imade G, Cooke G, McCormack S, Taylor-Robinson SD, Idoko J, Kanki P. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. World J Gastroenterol 2013; 19: 1602-1610 [PMID: 23538773 DOI: 10.3748/wjg.v19.i10.1602]
48. Mayaphi SH, Roussow TM, Masemola DP, Olorunju SA, Mphahlele MJ, Martin DJ. HBV/HIV co-infection: the dynamics of HBV in South African patients with AIDS. S Afr Med J 2012; 102: 157-162 [PMID: 22380911]
49. Franzeck FC, Ngwale R, Msongole B, Hamisi M, Abdul O, Henning L, Letang E, Mwaigomole G, Battegay M, Hatz C, Tanner M. Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural Tanzania. PLoS One 2013; 8: e58468 [PMID: 23469281 DOI: 10.1371/journal.pone.0058468]
50. Stabinski L, O'Connor S, Barnhart M, Kahn RJ, Hamm TE. Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings. J Acquir Immune Defic Syndr 2015; 68 Suppl 3: S274-S285 [PMID: 25768867 DOI: 10.1097/QAI.0000000000000496]
51. Garrido C, Trevino A, Bautista J. High rate of chronic hepatitis B, overt and occult, in a virological survey of hepatitis viruses and human retroviruses in Ghana. Antivir Ther 2011; 15: 1029-1034
52. N'Dri-Yoman T, Anglaret X, Messou E, Attia A, Polneau S, Toni T, Chenal H, Seyler C, Gabillard D, Wakasugi N, Eholié S, Danel C. Occult HBV infection in untreated HIV-infected adults in Côte d' Ivoire. Antivir Ther 2010; 15: 1029-1034 [PMID: 21041918 DOI: 10.3851/IMP1641]
53. Araujo NM, Branco-Vieira M, Silva AC, Pilotto JH, Grinsztejn B, de Almeida AJ, Trepo C, Gomes SA. Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters. Hepatol Res 2008; 38: 1194-1203 [PMID: 18624719 DOI: 10.1111/j.1872-034X.2008.00392.x]
54. Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, Hoepelman AI. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. J Med Virol 2011; 83: 929-934 [PMID: 21503902 DOI: 10.1002/jmv.22026]
55. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIVpositive patients from South Africa. J Clin Virol 2006; 35: 14-20 [PMID: 15916918 DOI: 10.1016/j.jcv.2005.04.003]
56. Bell TG, Makondo E, Martinson NA, Kramvis A. Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt-that is the question. PLoS One 2012; 7: e45750 [PMID: 23049685 DOI: 10.1371/journal. pone.0045750]
57. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, Sim J. Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol 1999; 58: 111-115 [PMID: 10335856]
58. Ugwuja EI, Ugwu NC. Seroprevalence of hepatitis B surface antigen and liver function tests among adolescents in Abakaliki, South Eastern Nigeria. Internet J Tropical Med 2010; 6: 2
59. Dumpis U, Holmes EC, Mendy M, Hill A, Thursz M, Hall A, Whittle H, Karayiannis P. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol 2001; 35: 99-104 [PMID: 11495049 DOI: 10.1016/S0168-8278(01)00064-2]
60. Otegbayo JA, Fasola FA, Abja A. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Trop Gastroenterol 2003; 24: 196-197 [PMID: 15164531]
61. McCarthy MC, el-Tigani A, Khalid IO, Hyams KC. Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Trans R Soc Trop Med Hyg 1994; 88: 534-536 [PMID: 7992329]
62. Sidibe S, Sacko BY, Traoré I. [Prevalence of serologic markers of the hepatitis B virus in pregnant women of Bamako, Mali]. Bull Soc Pathol Exot 2001; 94: 339-341 [PMID: 11845531]
63. Pido B, Kagimu M. Prevalence of hepatitis B virus (HBV) infection among Makerere University medical students. Afr Health Sci 2005; 5: 93-98 [PMID: 16006214]
64. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva, Switzerland: World Health Organization, 2011. Available from: URL: http://www.who.int/vmnis/indicators/haemoglobin.pdf
65. Apata IW, Averhoff F, Pitman J, Bjork A, Yu J, Amin NA, Dhingra N, Kolwaite A, Marfin A; Centers for Disease Control and Prevention (CDC). Progress toward prevention of transfusiontransmitted hepatitis B and hepatitis C infection-sub-Saharan Africa, 2000-2011. MMWR Morb Mortal Wkly Rep 2014; 63: 613-619 [PMID: 25055184]
66. Kurbanov F, Tanaka Y, Fujiwara K, Sugauchi F, Mbanya D, Zekeng L, Ndembi N, Ngansop C, Kaptue L, Miura T, Ido E, Hayami M, Ichimura H, Mizokami M. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol 2005; 86: 2047-2056 [PMID: 15958684 DOI: 10.1099/vir.0.80922-0]
67. Olinger CM, Venard V, Njayou M, Oyefolu AO, Maïga I, Kemp AJ, Omilabu SA, le Faou A, Muller CP. Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 2006; 87: 1163-1173 [PMID: 16603517 DOI: 10.1099/vir.0.81614-0]
68. Owiredu WK, Kramvis A, Kew MC. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D. J Med Virol 2001; 64: 441-454 [PMID: 11468728 DOI: 10.1002/jmv.1070]
69. Norder H, Couroucé AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289-309 [PMID: 15564741 DOI: 10.1159/000080872]
70. Bowyer SM, van Staden L, Kew MC, Sim JG. A unique segment of the hepatitis B virus group A genotype identified in isolates from South Africa. J Gen Virol 1997; 78 (Pt 7): 1719-1729 [PMID: 9225049]
71. Kramvis A, Weitzmann L, Owiredu WK, Kew MC. Analysis of the complete genome of subgroup A' hepatitis B virus isolates from South Africa. J Gen Virol 2002; 83: 835-839 [PMID: 11907333]
72. Sugauchi F, Kumada H, Acharya SA, Shrestha SM, Gamutan MT, Khan M, Gish RG, Tanaka Y, Kato T, Orito E, Ueda R, Miyakawa Y, Mizokami M. Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J Gen Virol 2004; 85: 811-820 [PMID: 15039524 DOI: 10.1099/vir.0.79811-0]
73. Hannoun C, Söderström A, Norkrans G, Lindh M. Phylogeny of African complete genomes reveals a West African genotype A subtype of hepatitis B virus and relatedness between Somali and Asian A1 sequences. J Gen Virol 2005; 86: 2163-2167 [PMID: 16033963 DOI: 10.1099/vir.0.80972-0]
74. Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, Muyembe Tamfum JJ, Nebie YK, Maiga I, Ammerlaan W, Fack F, Omilabu SA, Le Faou A, Muller CP. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 2004; 190: 400-408 [PMID: 15216479 DOI: 10.1086/421502]
75. Bozdayi G, Türkyilmaz AR, Idilman R, Karatayli E, Rota S, Yurdaydin C, Bozdayi AM. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. J Med Virol 2005; 76: 476-481 [PMID: 15977237 DOI: 10.1002/jmv.20386]
76. Cox LE, Arslan O, Allain JP. Characterization of hepatitis B virus in Turkish blood donors, and the prevalence of the SP1 splice variant. J Med Virol 2011; 83: 1321-1325 [PMID: 21678435 DOI: 10.1002/jmv.22118]
77. Kitab B, El Feydi AE, Afifi R, Derdabi O, Cherradi Y, Benazzouz M, Rebbani K, Brahim I, Salih Alj H, Zoulim F, Trepo C, Chemin I, Ezzikouri S, Benjelloun S. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect 2011; 63: 66-75 [PMID: 21640384 DOI: 10.1016/j.jinf.2011.05.007]
78. Zehender G, Ebranati E, Gabanelli E, Shkjezi R, Lai A, Sorrentino C, Lo Presti A, Basho M, Bruno R, Tanzi E, Bino S, Ciccozzi M, Galli M. Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin. PLoS One 2012; 7: e37198 [PMID: 22662136 DOI: 10.1371/journal.pone.0037198]
79. Zehender G, Shkjezi R, Ebranati E, Gabanelli E, Abazaj Z, Tanzi E, Kraja D, Bino S, Ciccozzi M, Galli M. Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. Infect Genet Evol 2012; 12: 291-298 [PMID: 22142487 DOI: 10.1016/j.meegid.2011.11.009]
80. Burnett RJ, Kramvis A, Dochez C, Meheus A. An update after 16 years of hepatitis B vaccination in South Africa. Vaccine 2012; 30 Suppl 3: C45-C51 [PMID: 22939021 DOI: 10.1016/j.vaccine.2012.02.021]
81. Irungu E, Mugo N, Ngure K, Njuguna R, Celum C, Farquhar C, Dhanireddy S, Baeten JM. Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya. J Infect Dis 2013; 207: 402-410 [PMID: 23175769 DOI: 10.1093/infdis/jis695]
82. Elbadawi IA. Reviving growth in the Arab world. Econ Dev Cult Change 2005; 53: 293-326 [DOI: 10.1086/425375]
83. Centers for Disease Control and Prevention. Health Information for International Travel 2016: The Yellow Book. Chapter 3-Infectious Diseases Related to Travel. Available from: URL: http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseasesrelated-to-travel/b-virus
84. Culcasi K. Constructing and naturalizing the Middle East. Geogr Rev 2010; 100: 583-597 [DOI: 10.1111/j.1931-0846.2010.00059.x]
85. Memish ZA, Knawy BA, El-Saed A. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis 2010; 14: e115-e120 [PMID: 19540786 DOI: 10.1016/j.ijid.2009.03.027]
86. Lavanchy D. Chronic viral hepatitis as a public health issue in the world. Best Pract Res Clin Gastroenterol 2008; 22: 991-1008 [PMID: 19187863 DOI: 10.1016/j.bpg.2008.11.002]
87. Al-Waleedi AA, Khader YS. Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden City, Yemen. East Mediterr Health J 2012; 18: 624-629 [PMID: 22888620]
88. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 2005; 45: 1973-1980 [PMID: 16371052 DOI: 10.1111/j.1537-2995.2005.00635.x]
89. Ataallah TM, Hanan KA, Maysoun KS, Sadoon AA. Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion Center in Baghdad, Iraq from 2006-2009. Saudi Med J 2011; 32: 1046-1050 [PMID: 22008925]
90. Saab BR, Nassar NT, Musharrafieh U, Araj GF, Khogali M. Prevalence of hepatitis B in a presumably healthy Lebanese population. J Med Liban 2007; 55: 11-14 [PMID: 17489302]
91. Al-Gani FA. Prevalence of HBV, HCV and HIV-1, 2 infections among blood donors in Prince Rashed Ben Al-Hassan hospital in North region of Jordan. Int J Biol Med Res 2011; 2: 912-916
92. Yassin K, Awad R, Tebi AJ, Queder A, Laaser U. Prevalence and risk factors of HBsAg in Gaza: implications for prevention and control. J Infect 2002; 44: 252-256 [PMID: 12099733]
93. Specialist Panel on Chronic Hepatitis B in the Middle East. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat 2012; 19: 9-22 [PMID: 22187943 DOI: 10.1111/j.1365-2893.2011.01511. x]
94. Al-Faleh FZ, Al-Jeffri M, Ramia S, Al-Rashed R, Arif M, Rezeig M, Al-Toraif I, Bakhsh M, Mishkkhas A, Makki O, Al-Freihi H, Mirdad S, AlJuma A, Yasin T, Al-Swailem A, Ayoola A. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect 1999; 38: 167-170 [PMID: 10424796 DOI: 10.1016/0163-4453(92 )93006-C]
95. Alfaleh F, Alshehri S, Alansari S, Aljeffri M, Almazrou Y, Shaffi A, Abdo AA. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect 2008; 57: 404-409 [PMID: 18829116 DOI: 10.1016/j.jinf.2008.08.008]
96. Yamada H, Fujimoto M, Svay S, Lim O, Hok S, Goto N, Ohisa M, Akita T, Matsuo J, Do SH, Katayama K, Miyakawa Y, Tanaka J. Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia. Hepatol Res 2015; 45: 480-487 [PMID: 24905888 DOI: 10.1111/hepr.12367]
97. Ol HS, Bjoerkvoll B, Sothy S, Van Heng Y, Hoel H, Husebekk A, Gutteberg T, Larsen S, Husum H. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia. Southeast Asian J Trop Med Public Health 2009; 40: 963-971 [PMID: 19842380]
98. Caruana SR, Kelly HA, De Silva SL, Chea L, Nuon S, Saykao P, Bak N, Biggs BA. Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong Region. Aust N Z J Public Health 2005; 29: 64-68 [PMID: 15782875 DOI: 10.1111/j.1467-842X.2005.tb00751.x]
99. Ang LW, Cutter J, James L, Goh KT. Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review. Vaccine 2013; 32: 103-110 [PMID: 24200974 DOI: 10.1016/j.vaccine.2013.10.057]
100. Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis 2012; 16: e82-e88 [PMID: 22178658 DOI: 10.1016/j.ijid.2011.10.009]
101. Cui F, Li L, Hadler SC, Wang F, Zheng H, Chen Y, Gong X, Hutin YJ, Cairns KL, Liang X, Yang W. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005. Vaccine 2010; 28: 5973-5978 [PMID: 20637773 DOI: 10.1016/j.vaccine.2010.06.111]
102. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27: 6550-6557 [PMID: 19729084 DOI: 10.1016/j.vaccine.2009.08.048]
103. Wang C, Sun J, Zhu B, Larsen S, Yu R, Wu J, Zhao W. Hepatitis B virus infection and related factors in hemodialysis patients in China-systematic review and meta-analysis. Ren Fail 2010; 32: 1255-1264 [PMID: 20954991 DOI: 10.3109/0886022X.2010.5173 54]
104. Yan YX, Gao YQ, Sun X, Wang W, Huang XJ, Zhang T, Li M, Zang CP, Li ZC, Wu H. Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect 2011; 139: 354-360 [PMID: 20598209 DOI: 10.1017/S0950268810001597]
105. Lee BS, Cho YK, Jeong SH, Lee JH, Lee D, Park NH, Ki M; Korean Hepatitis Epidemiology Study Group. Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol 2013; 85: 1327-1333 [PMID: 23723057 DOI: 10.1002/jmv.23594]
106. Kim H, Shin AR, Chung HH, Kim MK, Lee JS, Shim JJ, Kim BH. Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med 2013; 28: 413-419 [PMID: 23864799 DOI: 10.3904/kjim.2013.28.4.413]
107. Nurgalieva ZZ, Hollinger FB, Graham DY, Zhangabylova S, Zhangabylov A. Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan. World J Gastroenterol 2007; 13: 1204-1207 [PMID: 17451200 DOI: 10.3748/wjg.v13.i8.1204]
108. Batham A, Gupta MA, Rastogi P, Garg S, Sreenivas V, Puliyel JM. Calculating prevalence of hepatitis B in India: using population weights to look for publication bias in conventional meta-analysis. Indian J Pediatr 2009; 76: 1247-1257 [PMID: 20108060 DOI: 10.1007/s12098-009-0246-3]
109. Ozaras R, Inanc Balkan I, Yemisen M, Tabak F. Epidemiology of HBV subgenotypes D. Clin Res Hepatol Gastroenterol 2015; 39: 28-37 [PMID: 25037178 DOI: 10.1016/j.clinre.2014.06.005]
110. Pourkarim MR, Vergote V, Amini-Bavil-Olyaee S, Sharifi Z, Sijmons S, Lemey P, Maes P, Alavian SM, Van Ranst M. Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1. J Med Virol 2014; 86: 745-757 [PMID: 24532489 DOI: 10.1002/jmv.23864]
111. Xiang Y, Huang S, Xia J, Ye D, Chen P, Zhang L. Characterization of hepatitis B virus molecular genotypes in Chongqing and quantitative serological markers in patients during natural phases of chronic hepatitis B infection. Intervirology 2012; 55: 68-72 [PMID: 21293110 DOI: 10.1159/000323524]
112. Li XD, Wang L, Liu Y, Xu ZH, Dai JZ, Li L, Yao ZT, Xin SJ, Zhao JM, Xu DP. Characterization of hepatitis B virus genotypes/subgenotypes in 1, 301 patients with chronic hepatitis B in North China. Chin Med J (Engl) 2011; 124: 4178-4183 [PMID: 22340383]
113. Wang HY, Li D, Liu W, Jin X, Du B, Li YP, Gu HX, Zhang SY. Hepatitis B virus subgenotype C2 is the most prevalent subgenotype in northeast China. Clin Microbiol Infect 2010; 16: 477-481 [PMID: 19456822 DOI: 10.1111/j.1469-0691.2009.02834. x]
114. Yuan J, Zhou B, Tanaka Y, Kurbanov F, Orito E, Gong Z, Xu L, Lu J, Jiang X, Lai W, Mizokami M. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications. J Clin Virol 2007; 39: 87-93 [PMID: 17451999 DOI: 10.1016/j.jcv.2007.03.005]
115. Wang Z, Tanaka Y, Huang Y, Kurbanov F, Chen J, Zeng G, Zhou B, Mizokami M, Hou J. Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China. J Clin Microbiol 2007; 45: 1491-1496 [PMID: 17376881 DOI: 10.1128/JCM.02157-06]
116. You J, Sriplung H, Chongsuvivatwong V, Geater A, Zhuang L, Huang JH, Chen HY, Yu L, Tang BZ. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China. Hepatobiliary Pancreat Dis Int 2008; 7: 271-279 [PMID: 18522881]
117. Zhu CT, Dong CL. Characteristics of general distribution of hepatitis B virus genotypes in China. Hepatobiliary Pancreat Dis Int 2009; 8: 397-401 [PMID: 19666409]
118. Wang Z, Hou J, Zeng G, Wen S, Tanaka Y, Cheng J, Kurbanov F, Wang L, Jiang J, Naoumov NV, Mizokami M, Qi Y. Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China. J Viral Hepat 2007; 14: 426-434 [PMID: 17501764 DOI: 10.1111/j.1365-2893.2006.00813.x]
119. Wang B, Feng Y, Li Z, Duan H, Zhao T, Zhang A, Liu L, Baloch Z, Xia X. Distribution and diversity of hepatitis B virus genotypes in Yunnan, China. J Med Virol 2014; 86: 1675-1682 [PMID: 24992445 DOI: 10.1002/jmv.24002]
120. Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W, Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev 2010; 19: 777-786 [PMID: 20160279 DOI: 10.1158/1055-9965.EPI-09-1001]
121. Mumtaz K, Hamid S, Ahmed S, Moatter T, Mushtaq S, Khan A, Mizokami M, Jafri W. A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan: HBV genotypes in pakistan. Hepat Mon 2011; 11: 14-18 [PMID: 22087110]
122. Morozov V, Pisareva M, Groudinin M. Homologous recombination between different genotypes of hepatitis B virus. Gene 2000; 260: 55-65 [PMID: 11137291 DOI: 10.1016/S0378-1119(00)00424-8]
123. Ghosh S, Bane r j e e P, Deny P, Monda l RK, Nandi M, Roychoudhury A, Das K, Banerjee S, Santra A, Zoulim F, Chowdhury A, Datta S. New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India. J Viral Hepat 2013; 20: 209-218 [PMID: 23383660 DOI: 10.1111/j.1365-2893.2012.01655.x]
124. Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J 2008; 5: 156 [PMID: 19099581 DOI: 10.1186/1743-422X-5-156]
125. Banerjee P, Mondal RK, Nandi M, Ghosh S, Khatun M, Chakraborty N, Bhattacharya S, RoyChoudhury A, Banerjee S, Santra A, Sil S, Chowdhury A, Bhaumik P, Datta S. A rare HBV subgenotype D4 with unique genomic signatures identified in north-eastern India-an emerging clinical challenge? PLoS One 2014; 9: e109425 [PMID: 25295865 DOI: 10.1371/journal. pone.0109425.eCollection]
126. Hennessey K, Mendoza-Aldana J, Bayutas B, Lorenzo-Mariano KM, Diorditsa S. Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status. Vaccine 2013; 31 Suppl 9: J85-J92 [PMID: 24331026 DOI: 10.1016/j.vaccine.2012.10.082]
127. Kane MA, Hadler SC, Lee L, Shapiro CN, Cui F, Wang X, Kumar R. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization. Vaccine 2013; 31 Suppl 9: J15-J20 [PMID: 24331015 DOI: 10.1016/j.vaccine.2013.03.045]
128. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T. Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia. Arch Virol 2007; 152: 2017-2025 [PMID: 17680327 DOI: 10.1007/s00705-007-1031-0]
129. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T. Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia. J Med Virol 2010; 82: 1160-1167 [PMID: 20513079 DOI: 10.1002/jmv.21810]
130. Liaw YF, Brunetto MR, Hadziyannis S. The natural history of chronic HBV infection and geographical differences. Antivir Ther 2010; 15 Suppl 3: 25-33 [PMID: 21041901 DOI: 10.3851/IMP1621]
131. Tekin Koruk S, Koruk I, Gursoy B, Çalisir C, Kuksell F, Yildiz Zeyrek F. Hepatitis B and Hepatitis C Seroprevalence in the Center of Sanliurfa Province From Southeastern Anatolia Region and Related Risk Factors. Balkan Med J 2010; 27: 367-372 [DOI: 10.5174/tutfd.2009.02533.0]
132. Kevorkyan A, Teoharov P, Lernout T, Petrova N, Raycheva R, Ivanov I, van Damme P, Kojouharova M. Prevalence of HBV and HCV among outpatients in the Plovdiv region of Bulgaria, 2010-2011. J Med Virol 2015; 87: 401-406 [PMID: 25163778
133. Petrunov B, Kojouharova M, Teoharov P, Haidushka I, Sotirova P, Sredkova M, Russev I, Zacharakis G, Tzara F, Vafeadis N, Papathanasiou J, Papoutselis K. EU project interreg II: Seroepidemiology study of hepatitis C and B viral infections prevalencein Bulgaria and northern Greece. J Hepatol 2002; 36: Abstract 497
134. Fitzsimons D, Kojouharova M, Hallauer J, Hendrickx G, Vorsters A, Van Damme P. Burden and prevention of viral hepatitis in Bulgaria. Vaccine 2011; 29: 8471-8476 [PMID: 21951876
135. Voiculescu M, Iliescu L, Ionescu C, Micu L, Ismail G, Zilisteanu D, Radasan A, Micu G, Pertache I. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania. J Gastrointestin Liver Dis 2010; 19: 43-48 [PMID: 20361074]
136. Gay N, Edmunds W, Bah E, Nelson C. Estimating the global burden of hepatitis B. Geneva: World Health Organization, Department of Vaccines and Biologicals, 2001: 34 (349A)
137. Allain JP. Epidemiology of Hepatitis B virus and genotype. J Clin Virol 2006; 36 Suppl 1: S12-S17 [PMID: 16831687 DOI: 10.1016/S1386-6532(06)80003-X]
138. Ribeiro NR, Campos GS, Angelo AL, Braga EL, Santana N, Gomes MM, Pinho JR, De Carvalho WA, Lyra LG, Lyra AC. Distribution of hepatitis B virus genotypes among patients with chronic infection. Liver Int 2006; 26: 636-642 [PMID: 16842318 DOI: 10.1111/j.1478-3231.2006.01280.x]
139. Milionis C. Serological markers of Hepatitis B and C among juvenile immigrants from Albania settled in Greece. Eur J Gen Pract 2010; 16: 236-240 [PMID: 20954813 DOI: 10.3109/138147 88.2010.525631]
140. Kondili LA, Ulqinaku D, Hajdini M, Basho M, Chionne P, Madonna E, Taliani G, Candido A, Dentico P, Bino S, Rapicetta M. Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection 2007; 35: 94-97 [PMID: 17401713 DOI: 10.1007/s15010-007-6076-1]
141. Chironna M, Germinario C, Lopalco PL, Quarto M, Barbuti S. HBV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region). Epidemiol Infect 2000; 125: 163-167 [PMID: 11057972]
142. Durro V, Koraqi A, Saliasi S. Trends in the prevalence of transfusion-transmissible infections among blood donors in Albania. Clin Lab 2010; 56: 591-595 [PMID: 21141446]
143. Katsanos KH, Christodoulou DK, Zervou E, Babameto A, Kraja B, Hyphantis H, Karetsos V, Tsonis G, Basho J, Resuli BF, Tsianos EV. Hepatitis B remains a major health priority in Western Balkans: results of a 4-year prospective Greek-Albanian collaborative study. Eur J Intern Med 2009; 20: 698-702 [PMID: 19818290 DOI: 10.1016/j.ejim.2009.07.016]
144. Kondili LA, Cuko L, Chionne P, Candido A, Madonna E, Dentico P, Resuli B, Taliani G, Brunetto MR, Rapicetta M. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years. Eur J Gastroenterol Hepatol 2010; 22: 167-171 [PMID: 19734797 DOI: 10.1097/MEG.0b013e328330d410]
145. Resuli B, Prifti S, Kraja B, Nurka T, Basho M, Sadiku E. Epidemiology of hepatitis B virus infection in Albania. World J Gastroenterol 2009; 15: 849-852 [PMID: 19230046 DOI: 10.3748/wjg.15.849]
146. Stępień M, Piwowarow K. Hepatitis B in Poland in 2012. Przegl Epidemiol 2014; 68: 257-363, 363-367 [PMID: 25135511]
147. Vilibić-Cavlek T, Kucinar J, Ljubin-Sternak S, Kaić B, Lazarić-Stefanović L, Kolarić B. Prevalence of viral hepatitis in Croatian adult population undergoing routine check-up, 2010-2011. Cent Eur J Public Health 2014; 22: 29-33 [PMID: 24844103]
148. [The annual report of the main indicators in public health in Russia]. Moscow, Russia. Vol. 1, Feb 2011
149. Schaefer S. Hepatitis B virus genotypes in Europe. Hepatol Res 2007; 37: S20-S26 [PMID: 17627630 DOI: 10.1111/j.1872-034X.2007.00099.x]
150. Constantinescu I, Nedelcu F, Toader MA, Daniela V. Clinical and therapeutical importance of HBV genotyping in Romania. J Med Life 2008; 1: 165-173 [PMID: 20108463]
151. De Maddalena C, Giambelli C, Tanzi E, Colzani D, Schiavini M, Milazzo L, Bernini F, Ebranati E, Cargnel A, Bruno R, Galli M, Zehender G. High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus. Virology 2007; 365: 113-124 [PMID: 17451771 DOI: 10.1016/j.virol.2007.03.015]
152. Deterding K, Constantinescu I, Nedelcu FD, Gervain J, Nemecek V, Srtunecky O, Vince A, Grgurevic I, Bielawski KP, Zalewska M, Bock T, Ambrozaitis A, Stanczak J, Takács M, Chulanov V, Slusarczyk J, Drazd'áková M, Wiegand J, Cornberg M, Manns MP, Wedemeyer H. Prevalence of HBV genotypes in Central and Eastern Europe. J Med Virol 2008; 80: 1707-1711 [PMID: 18712830 DOI: 10.1002/jmv.21294]
153. Olinger CM, Lazouskaya NV, Eremin VF, Muller CP. Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences. Clin Microbiol Infect 2008; 14: 575-581 [PMID: 18373690 DOI: 10.1111/j.1469-0691.2008.01988.x]
154. Slusarczyk J, Białkowska J, Bucholc B, Wiatrzyk A, Górska P, Jabłkowski M. [HBV genotypes among patients with chronic hepatitis B in the area of central Poland]. Przegl Epidemiol 2006; 60: 555-561 [PMID: 17249180]
155. Bielawski KP, Stalke P. Molecular epidemiology of chronic hepatitis B virus infection in northern Poland. J Clin Virol 2005; 34 Suppl 1: S63-S69 [PMID: 16461226 DOI: 10.1016/S1386-6532(05)80012-5]
156. Ciccozzi M, Babakir-Mina M, Lo Presti A, Salpini R, Cella E, Gabanelli E, Teoharov P, Kevorkyan A, Perno CF, Zehender G, Ciotti M. Molecular analysis of hepatitis B virus in Bulgaria. J Med Virol 2013; 85: 49-54 [PMID: 23154875 DOI: 10.1002/jmv.23432]
157. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38: S158-S168 [PMID: 15602165]
158. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Euro Surveill 2008; 13: pii 18880 [PMID: 18761967]
159. van Houdt R, Bruisten SM, Geskus RB, Bakker M, Wolthers KC, Prins M, Coutinho RA. Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. J Viral Hepat 2010; 17: 108-114 [PMID: 19811610 DOI: 10.1111/j.1365-2893.2009.01158.x]
160. Tallo T, Tefanova V, Priimägi L, Schmidt J, Katargina O, Michailov M, Mukomolov S, Magnius L, Norder H. D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 2008; 89: 1829-1839 [PMID: 18632953 DOI: 10.1099/vir.0.83660-0]
161. Tallo T, Norder H, Tefanova V, Krispin T, Priimägi L, Mukomolov S, Mikhailov M, Magnius LO. Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4. J Med Virol 2004; 74: 221-227 [PMID: 15332270 DOI: 10.1002/jmv.20169]
162. Nardone A, Anastassopoulou CG, Theeten H, Kriz B, Davidkin I, Thierfelder W, O'Flanagan D, Bruzzone B, Mossong J, Boot HJ, Butur D, Slaciková M, Panait ML, Hellenbrand W, DE Melker H, Sobotová Z, Icardi G, Andrews N, Pebody RG, VAN Damme P, Kafatos G, Miller E, Hatzakis A. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect 2009; 137: 961-969 [PMID: 19102797 DOI: 10.1017/S0950268808001672]
163. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010; 14: 1-21, vii [PMID: 20123436 DOI: 10.1016/j.cld.2009.11.009]
164. Alvarado-Mora MV, Pinho JR. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther 2013; 18: 429-433 [PMID: 23792375 DOI: 10.3851/IMP2595]
165. Roman S, Jose-Abrego A, Fierro NA, Escobedo-Melendez G, Ojeda-Granados C, Martinez-Lopez E, Panduro A. Hepatitis B virus infection in Latin America: a genomic medicine approach. World J Gastroenterol 2014; 20: 7181-7196 [PMID: 24966588 DOI: 10.3748/wjg.v20.i23.7181]
166. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34 Suppl 1: S1-S3 [PMID: 16461208 DOI: 10.1016/S1386-6532(05)00384-7]
167. Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008; 359: 1486-1500 [PMID: 18832247 DOI: 10.1056/NEJMra0801644]
168. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000; 18 Suppl 1: S17-S19 [PMID: 10683537 DOI: 10.1016/S0264-410X(99)00455-7]
169. World Health Organization. International travel and health. Hepatitis B. Available from: URL: http://www.who.int/ith/diseases/hepatitisB/en/
170. Roman S, Tanaka Y, Khan A, Kurbanov F, Kato H, Mizokami M, Panduro A. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol 2010; 82: 1527-1536 [PMID: 20648606 DOI: 10.1002/jmv.21846]
171. Roman S, Panduro A, Aguilar-Gutierrez Y, Maldonado M, Vazquez-Vandyck M, Martinez-Lopez E, Ruiz-Madrigal B, Hernandez-Nazara Z. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int 2009; 3: 343-355 [PMID: 19669360 DOI: 10.1007/s12072-008-9115-9]
172. Bertolini D, Moreira R, Soares M, Bensabath G, Lemos M, Mello Imvgc PJ. Genotyping of hepatitis B virus in indigenous populations from Amazon region, Brazil. Virus Rev Res 2000; 5 (2-suppl 1): 101
173. Castilho Mda C, Oliveira CM, Gimaque JB, Leão JD, Braga WS. Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon. Am J Trop Med Hyg 2012; 87: 768-774 [PMID: 22908032 DOI: 10.4269/ajtmh.2012.12-0083]
174. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002; 83: 2059-2073 [PMID: 12124470]
175. Devesa M, Pujol FH. Hepatitis B virus genetic diversity in Latin America. Virus Res 2007; 127: 177-184 [PMID: 17280734 DOI: 10.1016/j.virusres.2007.01.004]
176. Norder H, Hammas B, Lee SD, Bile K, Couroucé AM, Mushahwar IK, Magnius LO. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993; 74 (Pt 7): 1341-1348 [PMID: 8336122 DOI: 10.1099/0022-1317-74-7-13 41]
177. Panduro A, Maldonado-Gonzalez M, Fierro NA, Roman S. Distribution of HBV genotypes F and H in Mexico and Central America. Antivir Ther 2013; 18: 475-484 [PMID: 23792777 DOI: 10.3851/IMP2605]
178. Zhou Y, Holmes EC. Bayesian estimates of the evolutionary rate and age of hepatitis B virus. J Mol Evol 2007; 65: 197-205 [PMID: 17684696 DOI: 10.1007/s00239-007-0054-1]
179. Barbini L, Elizalde M, Torres C, Campos R. Molecular epidemiology and genetic diversity of hepatitis B virus in Mar del Plata city, Argentina. Infect Genet Evol 2013; 19: 152-163 [PMID: 23871776 DOI: 10.1016/j.meegid.2013.07.007]
180. Martinez AA, Zaldivar Y, Hong CCh, Alvarado-Mora MV, Smith R, Ortiz AY, Pinho JR, Cristina J, Pascale JM. Molecular characterisation of hepatitis B virus in the resident Chinese population in Panama City. Mem Inst Oswaldo Cruz 2013; 108: 541-547 [PMID: 23903967 DOI: 10.1590/S0074-02762013000500002]
181. Khan A, Tanaka Y, Saito H, Ebinuma H, Sekiguchi H, Iwama H, Wakabayashi G, Kamiya T, Kurbanov F, Elkady A, Mizokami M. Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia. Virus Res 2008; 132: 174-180 [PMID: 18207274 DOI: 10.1016/j.virusres.2007.12.005]
182. Roman S, Fierro NA, Moreno-Luna L, Panduro A. Hepatitis B virus genotype H and environmental factors associated to the low prevalence of hepatocellular carcinoma in Mexico. J Cancer Ther 2013; 2A: 367-376 [DOI: 10.4236/jct.2013.42A044]
183. Pujol FH, Roman S, Panduro A, Navas MC, Lampe E. Hepatocellular carcinoma in Latin America. In: Isabelle Chemin, Editor. Hepatocellular Carcinoma: A Global Challenge. New York: Nova Science Publishers Inc, 2012: 55-68
184. Torres JR. Hepatitis B and hepatitis delta virus infection in South America. Gut 1996; 38 Suppl 2: S48-S55 [PMID: 8786054 DOI: 10.1136/gut.38.Suppl-2.S48]
185. Braga WS, Castilho Mda C, Borges FG, Martinho AC, Rodrigues IS, Azevedo EP, Scazufca M, Menezes PR. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon. Rev Soc Bras Med Trop 2012; 45: 13-17 [PMID: 22370822 DOI: 10.1590/S0037-86822012000100004]
186. de la Hoz F, Perez L, de Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis 2008; 12: 183-189 [PMID: 17913535 DOI: 10.1016/j.ijid.2007.06.010]